Opportunity Analysis and Industry Forecast, 2016-2023 Vaccines Market Global Opportunity Analysis and Industry Forecast, 2017-2023 No. of Pages: 240 Publish: May 2017
Vaccines Market • The emerging vaccines for malaria, dengue, Zika, HIV, Ebola, and other serotypes are expected to propel the market growth in the forthcoming years. In addition, the ongoing vaccination programs and the recommendation doses for respective vaccine in the developing and the under-developed countries have supplemented the market growth. • - Sriram Radhakrishnan
Vaccines Market Overview • Global Vaccines Market was valued at $31,216 million in 2016, and is expected to reach $65,148 million in 2023, and register a CAGR of 10.9%, during the forecast period, 2017‐ 2023. • Vaccine is a biological preparation that is administered to produce acquired immunity in patients. Administration of vaccines aids to enhance the immune response against a specific pathogen. • Vaccinations play a crucial role to maintain sustainable health of people across different countries; hence, they are employed in various regional disease-prevention strategies. • The demand for vaccinations has increased over the last few years, owing to the increase in incidence of both viral and bacterial infectious diseases.
Vaccines Market Key Benefits A • It provides an in-depth analysis of current trends and future estimations to elucidate the imminent investment pockets • It offers a comprehensive analysis of factors that drive and restrict the market growth • It presents a quantitative analysis of the industry to enable the stakeholders to capitalize on the prevailing market opportunities • It provides an extensive analysis of key segments to understand the type of products and indications used globally • It includes profiles of key market players and their strategies to comprehend the competitive outlook of the market.
Vaccines Market Key Findings • The recombinant vaccines segment is anticipated to grow at the highest growth rate during the forecast period. • The human papilloma virus (HPV) vaccines segment is expected to grow at a rapid rate, registering a CAGR of 12.4% from 2017 to 2023. • North America dominated the global vaccines market, accounting for maximum share of overall market in 2016. • Asia-Pacific is exhibited to grow at a high growth rate of 12.0%, owing to the high demand for vaccination in densely populated area, such as India and China. • The pediatric vaccines segment generated highest revenue in 2016, and is expected to continue its dominance in the future as well.
Vaccines Market By Geography • North America, Europe, Asia-Pacific, LAMEA
Key Players in Industry • Astellas Pharma Inc. • Astrazeneca Plc. (Medimmune, LLC.) • CSL Limited • Emergent Biosolutions, Inc. • Glaxosmithkline Plc. • Johnson & Johnson • Merck & Co., Inc. • Pfizer Inc. • Sanofi Pasteur • Serum Institute of India Pvt. Ltd. • Download Sample Copy of this Report Click Here
Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/vaccines-market Follow Us On